Overview

Safety & Efficacy WC3011 in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
Study if WC3011 is effective and safe in the treatment of postmenopausal vaginal dryness due to vulvovaginal atrophy.
Phase:
Phase 3
Details
Lead Sponsor:
Warner Chilcott